Family · Pharmaceutical analytical standards
Zelebrudomide
An investigational molecule of the PROTAC class, studied against B-cell blood cancers such as chronic lymphocytic leukaemia and mantle cell lymphoma: instead of merely blocking the kinase BTK, it makes the cell itself destroy it. This family brings together the active ingredient and other impurities.
Did you know?It hits three proteins at once: besides BTK it removes Ikaros and Aiolos, two factors that regulate the immune system. During development it was known by the code name NX-2127.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
